The World Health Organization’s (WHO) recent recommendation on who should take the Chinese Communist Party (CCP) Virus vaccine said that children should not get immunized at this time.
“Children are at [a] very, very low risk of actually getting COVID disease,” claimed Dr. Kate O’Brien, a pediatrician, and director of WHO’s vaccine division. Vaccinating children, she said, was intended to prevent the spread of disease rather than to keep them from becoming sick or dying.
An updated report on June 22 from WHO’s website explained, “Children and adolescents tend to have milder disease compared to adults. So unless they are part of a group at higher risk of severe COVID-19, it is less urgent to vaccinate them than older people, those with chronic health conditions, and health workers.”
Although a growing number of wealthy countries allow immunization for adolescents and children, O’Brien previously emphasized in a social media meeting on June 3 that CCP Virus vaccination campaigns should not be aimed at children.
She also said that vaccinating youngsters before returning them to school was not essential. “Immunization of children in order to send them back to school is not the predominant requirement for them to go back to school safely,” stated O’Brien.
Children should not be vaccinated against the CCP Virus because the shots provide little benefit.
According to The Defender, The U.S. Food and Drug Administration (FDA) conducted a meeting on June 10 to explore giving Emergency Use Authorization (EUA) for CCP Virus vaccinations for children under 12. Several specialists have spoken out opposing the idea, claiming that the advantages do not exceed the hazards to youngsters.
During the open public hearing conference, Peter Doshi, Ph.D., associate professor at the University of Maryland School of Pharmacy and senior editor of The BMJ (Originally called the British Medical Journal), stated that no urgency would justify utilizing EUA to permit CCP Virus vaccines for kids.
The Centers for Disease Control and Prevention (CDC) statistics indicated that 23% of 0- to 4-year-olds and 42% of 5- to 17-year-olds have already gotten the CCP Virus and have a robust natural immune system, Doshi cited.
CDC statistics from Jan. 1 to March 31 found only 204 hospitalized cases and 0 fatalities in the 12- to 17-year-old age group due to the CCP Virus, according to Dr. Sidney Wolf, founder and senior consultant of Health Research Group.
Dr. Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office, provided CDC data that revealed a higher-than-expected amount of heart infection cases among youngsters who lately had their second doses of mRNA vaccine. After the injections, the agency discovered 226 records that potentially satisfy the agency’s “working case definition” of myocarditis and pericarditis.
Through May 31, 79 occurrences of myocarditis and pericarditis were documented among 16- to 17-year-olds. Shimabukuro stated that the predicted rate among people in this age range was between 2 and 19 cases during his address.
According to the CDC, there were also 196 instances of myocarditis and pericarditis among 18- to 24-year-olds. The predicted number of cases was between 8 and 83.
Reports of myocarditis and pericarditis (heart infection) in all age categories documented numbered 1,117 in the United States following CCP Virus vaccination between Dec. 14, 2020, and June 11, 2021, according to the most recent data of The Vaccine Adverse Event Reporting System. There were 109 cases among youngsters aged 12 to 17 years old, with 108 linked to Pfizer.
Pfizer’s CCP Virus vaccine is now approved for urgent treatment in children as young as 12 years old. The Moderna company has asked the FDA to allow its use in youngsters as young as 12. It is approved for persons aged 18 and older. The vaccine from Johnson & Johnson is only for people from the age of 18 and above.